Type 2 Diabetes

Overview: This research study compares the study medicine, Zenagamtide, with insulin glargine in people with type 2 diabetes, to evaluate blood-sugar control, body weight, safety, including cardiovascular outcomes. Participants will be 45 years or older, male or female, and diagnosed with type 2 diabetes at least 6 months ago.

Overview: This global study evaluates the effectiveness of combining an investigational medicine with empagliflozin in reducing serious heart health events.

Overview: Evaluation of the Fully Closed Loop Omnipod® System for Safety and Efficacy in Adults with Type 2 Diabetes.